Shiva Roshan-Milani

Shiva Roshan-Milani

Auto-generated profile, based on publicly available information

Shiva Roshan-Milani

Neurophysiology Research Center, Cellular and Molecular Medicine Research Institute, Urmia University of Medical Sciences, Urmia, Iran

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2021 in Stress
Verified
Journal Article
Closed access
SRShiva Roshan-Milani
Shiva Roshan-Milani
BSBehdad Seyyedabadi
Behdad Seyyedabadi
ESEhsan Saboory
Ehsan Saboory
NPNegin Parsamanesh
Negin Parsamanesh
NMNasrin Mehranfard
Nasrin Mehranfard
Neuroplasticity during the prenatal period allows neurons to regenerate anatomically and functionally for re-programming the brain development. During this critical period of fetal programming, the fetus phenotype can change in accordance with environmental stimuli such as stress exposure. Prenatal stress (PS) can exert important effects on brain development and result in permanent alterations with long-lasting consequences on the physiology and behavior of the offspring later in life. Neuroinflammation, as well as GABAergic and glutamatergic dysfunctions, has been implicated as potential mediators of behavioral consequences of PS. Hyperexcitation, due to enhanced excitatory transmission or reduced inhibitory transmission, can promote anxiety. Alterations of the GABAergic and/or glutamatergic signaling during fetal development lead to a severe excitatory/inhibitory imbalance in neuronal circuits, a condition that may account for PS-precipitated anxiety-like behaviors. This review summarizes experimental evidence linking PS to an elevated risk to anxiety-like behaviors and interprets the role of the neuroinflammation and alterations of the brain GABAergic and glutamatergic transmission in this phenomenon. We hypothesize this is an imbalance in GABAergic and glutamatergic circuits (as a direct or indirect consequence of neuroinflammation), which at least partially contributes to PS-precipitated anxiety-like behaviors and primes the brain to be vulnerable to anxiety disorders. Therefore, pharmacological interventions with anti-inflammatory activities and with regulatory effects on the excitatory/inhibitory balance can be attributed to the novel therapeutic target for anxiety disorders.

1 June 2016 in Reproductive Toxicology
Verified
Journal Article
Closed access
NPNazila Pourhassanali
Nazila Pourhassanali
SRShiva Roshan-Milani
Shiva Roshan-Milani
FKFatemeh Kheradmand
Fatemeh Kheradmand
MMMorteza Motazakker
Morteza Motazakker
MBmorteza bagheri
morteza bagheri
ESEhsan Saboory
Ehsan Saboory

5 May 2011 in Developmental Psychobiology
Verified
Journal Article
Closed access
PDF file
RARamin Ahmadzadeh
Ramin Ahmadzadeh
ESEhsan Saboory
Ehsan Saboory
SRShiva Roshan‐Milani
Shiva Roshan‐Milani
APAli Asghar Pilehvarian
Ali Asghar Pilehvarian

10 October 2013 in International Journal of Developmental Neuroscience
Verified
Journal Article
Closed access
ETElham Tavassoli
Elham Tavassoli
ESEhsan Saboory
Ehsan Saboory
MTMasood Teshfam
Masood Teshfam
YRYusef Rasmi
Yusef Rasmi
SRShiva Roshan‐Milani
Shiva Roshan‐Milani
AHAli Kalantari Hesari
Ali Kalantari Hesari

1 July 2017 in Epilepsy & Behavior
Verified
Journal Article
Closed access
PGPeyman Gholipoor
Peyman Gholipoor
ESEhsan Saboory
Ehsan Saboory
AGAhad Ghazavi
Ahad Ghazavi
AKArezoo Kiyani
Arezoo Kiyani
SRShiva Roshan-Milani
Shiva Roshan-Milani
YRYousef Rasmi
Yousef Rasmi

1 May 2010 in Microbes and Infection
Verified
Journal Article
Closed access
NJNima Hosseini Jazani
Nima Hosseini Jazani
MKMojtaba Karimzad
Mojtaba Karimzad
EMEbrahim Mazloomi
Ebrahim Mazloomi
MSMohammad Sohrabpour
Mohammad Sohrabpour
ZHZuhair Muhammad Hassan
Zuhair Muhammad Hassan
SSShahram Shahabi
Shahram Shahabi